(Q39874006)

English

Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines

scientific article published on February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 September 2017

Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines (English)

1 reference

Europe PubMed Central

15 September 2017

radiation therapy

0 references

0 references

1 reference

based on heuristic

inferred from title

Stephanie E. Combs

1

1 reference

Europe PubMed Central

15 September 2017

6

object named as

Jurgen Debus

1 reference

Europe PubMed Central

15 September 2017

author name string

Jessica Bohl

2

1 reference

Europe PubMed Central

15 September 2017

Thilo Elsasser

3

1 reference

Europe PubMed Central

15 September 2017

Klaus-Josef Weber

4

1 reference

Europe PubMed Central

15 September 2017

Daniela Schulz-Ertner

5

1 reference

Europe PubMed Central

15 September 2017

Wilma K Weyrather

7

1 reference

Europe PubMed Central

15 September 2017

publication date

1 February 2009

1 reference

Europe PubMed Central

15 September 2017

International Journal of Radiation Biology

1 reference

Europe PubMed Central

15 September 2017

85

1 reference

Europe PubMed Central

15 September 2017

2

1 reference

Europe PubMed Central

15 September 2017

126-137

1 reference

Europe PubMed Central

15 September 2017

Combined radiation and p53 gene therapy of malignant glioma cells

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma.

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

In vitro responsiveness of glioma cell lines to multimodality treatment with radiotherapy, temozolomide, and epidermal growth factor receptor inhibition with cetuximab

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Cluster effects within the local effect model

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines.

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

High linear energy transfer carbon radiation effectively kills cultured glioma cells with either mutant or wild-type p53.

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Treatment planning for heavy ion radiotherapy: clinical implementation and application

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Self-destruction and tolerance in resistance of mammalian cells to alkylation damage

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Cytoprotection by WR-1065, the active form of amifostine, is independent of p53 status in human malignant glioma cell lines

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

The Charing Cross Hospital experience with temozolomide in patients with gliomas.

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours.

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Exceptional sensitivity of testicular germ cell tumour cell lines to the new anti-cancer agent, temozolomide

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Computation of cell survival in heavy ion beams for therapy. The model and its approximation.

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Carbon ion radiotherapy of skull base chondrosarcomas

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Particle radiation therapy using proton and heavier ion beams

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Relative biological effectiveness for cell-killing effect on various human cell lines irradiated with heavy-ion medical accelerator in Chiba (HIMAC) carbon-ion beams

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Cell cycle checkpoint and apoptosis induction in glioblastoma cells and fibroblasts irradiated with carbon beam

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Survival of human glioma cells treated with various combination of temozolomide and X-rays

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

RBE for carbon track-segment irradiation in cell lines of differing repair capacity

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death

1 reference

https://api.crossref.org/works/10.1080%2F09553000802641151

21 January 2018

Identifiers

10.1080/09553000802641151

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39874006&oldid=2091873947"